Metformin in Diabetic Patients Undergoing Coronary Angiography
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The present study aims to evaluate the strict application of the 2018 European Society of
Cardiology guidelines on myocardial revascularization, that recommends to check renal
function if patients have taken metformin immediately before angiography and withhold
metformin if renal function deteriorates.
The aim of this study is to assess the safety of metformin in diabetic patients undergoing
coronary angiography in terms of risk of lactic acidosis and to individuate eventual
predictors of augmented lactic acid after coronary angiography.